Navigation Links
Detke Joins MedAvante as Chief Medical Officer
Date:3/12/2009

Former Eli Lilly executive Michael J. Detke, MD, PhD, is frequent presenter on the causes of failed clinical studies for central nervous system (CNS) therapeutics and methods for improvement

HAMILTON, N.J., March 12 /PRNewswire/ -- MedAvante, Inc. the leader in centralized psychiatric patient evaluation, announced today that Michael Detke, MD, PhD, has joined the company as Chief Medical Officer and Director of the MedAvante Research Institute. Dr. Detke comes to MedAvante from Eli Lilly, Inc., in Indianapolis, Indiana, where he was Executive Director and head of early phase development of CNS therapeutics.

"We are honored to have Michael join our team," says Paul Gilbert, Chief Executive Officer of MedAvante. "At Lilly, Mike led early phase development of one of the industry's deepest and strongest pipelines of CNS products. His earlier work on Cymbalta(R) and Prozac(R) proves that he is a top-caliber scientist dedicated to developing CNS therapeutics. At MedAvante, Mike will apply his leadership abilities, scientific expertise, and commitment to quality assurance to help us deliver our leading-edge methodology for removing sources of bias and variability, increasing signal detection, and reducing the high rate of failed CNS trials."

Dr. Detke says, "MedAvante holds great promise for ensuring the future success of CNS therapeutics. For decades and now acutely, our industry has struggled with the problems of rater bias and an inability to separate placebo response from active-drug response. MedAvante offers a potential powerful solution for these problems. Our methodology to substantially increase the efficiency of clinical studies can help bring new treatments to market for patients suffering from debilitating CNS diseases. Furthermore, it can help to elucidate efficacy further, to help patients and doctors understand, for example, the relative efficacy of different drugs for a disorder, or different doses of a drug."

Prior to joining MedAvante, Dr. Detke worked for Eli Lilly Research Laboratories in Indianapolis, for more than 8 years, most recently as Executive Director overseeing all CNS products in early phase development for psychiatry, neurology and pain indications. He is Associate Clinical Professor of Psychiatry at Indiana University School of Medicine, where he teaches and supervises medical students and residents in patient care. He is Research Associate at Harvard Medical School. He has been the principal investigator in numerous studies of CNS therapeutics. Dr. Detke has published more than 50 articles in peer-reviewed journals, and has served as a reviewer for numerous such journals. He is a member in prestigious scientific organizations such as ACNP and SOBP. He graduated summa cum laude with a BA and MS in Psychology at Yale University and his MD and PhD at the University of Pennsylvania; he completed his medical internship and psychiatry residency at Harvard University.

About MedAvante, Inc

MedAvante is a global provider of centralized expert psychological rating services to the pharmaceutical, biotechnology, and medical device industries. MedAvante is a pioneer in developing a solution for one of the most intractable problems in CNS clinical trials: the high rate of uninformative or failed studies. MedAvante applies unique methods to systematically remove potential sources of bias and variability from the assessment process. By centralizing assessments with expert, standardized, objective, clinical interviewers over MedAvante's two-way, real-time, high-quality videoconferencing, MedAvante makes subjective assessments of drug efficacy increasingly objective. As a result, sponsors can achieve increased study power and reduced trial-failure rates enabling them to bring more effective CNS drugs to market sooner. MedAvante operates facilities in Hamilton, New Jersey; Los Angeles, California; and Madison, Wisconsin. MedAvante is backed by over $34 million in investor financing including $20 Million in growth financing by Goldman Sachs and Trevi Health Ventures. For more information about MedAvante, visit www.medavante.net.


'/>"/>
SOURCE MedAvante, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jocelyn Frederick Joins Tsoi/Kobus & Associates as Principal
2. Michael J. Fox Foundation Joins Effort to Recruit 10,000 People With Parkinsons Disease to New Web-Based PD Research Community
3. Veteran Rehab Specialist, James Conwell, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania
4. KevinMD.com Joins the HCPLive.com Network
5. Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina
6. Nurse & Veteran Rehab Specialist, Terri Witten, Joins Fast-Growing Alliance Seating & Mobility in Ohio
7. Veteran Rehab Specialist, Donna Cole, Joins Fast-Growing Alliance Seating & Mobility in California
8. Veteran Rehab Specialist, David Glancy, Joins Fast-Growing Alliance Seating & Mobility in Michigan
9. Wound Management Technologies Joins IMCO Vendor Network to Expand Sales Nationwide
10. Michael Forte Joins CONNEXION Healthcare as Chief Operations Officer
11. Julie Gallagher Joins Akerman Senterfitts Healthcare Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology: